• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vivo predictive toxicogenomics.

作者信息

Porter Mark W

机构信息

Department of Toxicogenomics, Gene Logic Inc., Gaithersburg, Maryland, USA.

出版信息

Methods Mol Biol. 2008;460:113-43. doi: 10.1007/978-1-60327-048-9_6.

DOI:10.1007/978-1-60327-048-9_6
PMID:18449485
Abstract

Reference databases consisting of large sample numbers and high-dimensional microarray data are now available for the investigation of adverse events in animal model systems such as the rat. This large volume of data, accompanied by appropriate study designs, compound and dose selection procedure, and minimization of technical and biological confounding effects, can yield successful predictive models for a variety of hypotheses. The process of training, validating, and implementing predictive models is cyclical and complex. This chapter highlights individual decisions that need to be made before, during, and after a model or set of models has been trained, with an emphasis on proper statistical methods and suitable interpretation of the results.

摘要

相似文献

1
In vivo predictive toxicogenomics.
Methods Mol Biol. 2008;460:113-43. doi: 10.1007/978-1-60327-048-9_6.
2
Design issues in toxicogenomics using DNA microarray experiment.
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):200-8. doi: 10.1016/j.taap.2005.01.045.
3
Role of statistics in toxicogenomics.
Methods Mol Biol. 2008;460:69-87. doi: 10.1007/978-1-60327-048-9_4.
4
Microarray probe mapping and annotation in cross-species comparative toxicogenomics.
Methods Mol Biol. 2008;460:159-83. doi: 10.1007/978-1-60327-048-9_8.
5
Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?制药行业中的毒理基因组学:空洞的承诺还是真正的益处?
Mutat Res. 2005 Aug 4;575(1-2):102-15. doi: 10.1016/j.mrfmmm.2005.02.009. Epub 2005 Apr 25.
6
Quality control of microarray assays for toxicogenomic and in vitro diagnostic applications.
Methods Mol Biol. 2008;460:45-68. doi: 10.1007/978-1-60327-048-9_3.
7
Transcriptomics in predictive toxicology.
Curr Opin Drug Discov Devel. 2002 Jan;5(1):90-7.
8
Toxicogenomics in biomarker discovery.生物标志物发现中的毒理基因组学。
Methods Mol Biol. 2008;460:185-94. doi: 10.1007/978-1-60327-048-9_9.
9
[Toxicogenomics--a new paradigm of toxicology and birth of reverse toxicology].
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2002(120):39-52.
10
Public consortium efforts in toxicogenomics.毒理基因组学领域的公共财团合作项目。
Methods Mol Biol. 2008;460:221-38. doi: 10.1007/978-1-60327-048-9_11.